Effect of Neonatal Hyperoxia on Alveolar Development and Infection
Effect of Neonatal Hyperoxia on Alveolar Development and Infection
批准号:
9172674
负责人:
Michael A O'Reilly
金额:
$11.51万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-12-10 至 2018-01-31
关键词:
AffectAgeAgingAirAlveolarAlveolar CellAlveolusAnimal ModelAntibodiesBirthCCL2 geneCD8B1 geneCell surfaceCellsChildDevelopmentDiphtheriaDiseaseDistalElderlyEnvironmentEpithelialExhibitsFibrosisGene Expression ProfileGeneticGoalsHealthHospitalizationHumanImmuneImmune responseIndividualInfectionInflammationInfluenza A Virus, H1N1 SubtypeInfluenza A virusInjuryLaboratoriesLeadLifeLiquid substanceLungLung diseasesMapsMedicalMorbidity - disease rateMusNeonatal Hyperoxic InjuryOxygenPremature InfantPrimary InfectionProductionProteinsPublic HealthPuerto RicoReporterResearchResearch SupportRibonucleasesRiskSeveritiesSiblingsStem cellsStructure of respiratory epitheliumT-LymphocyteTestingToxinType II Epithelial Receptor CellViralViral Respiratory Tract InfectionVirusVirus DiseasesWorkadaptive immunityagedbaseeosinophilhuman morbidityhuman mortalityimprovedlung developmentlung injurymolecular phenotypenovel therapeuticsoxidative damageparent grantpathogenpostnatalrespiratoryresponseseasonal influenzasenescenceyoung adult
中文摘要
项目概要(摘要)
季节性甲型流感病毒(IAV)是造成人类发病率和死亡率的主要原因
在全世界都有。老年人呼吸系统并发症和住院的风险最高,
幼儿,以及任何有某些潜在或以前的医疗条件,如出生
早产儿由于早产儿经常暴露在高氧环境中,
出生时异常的氧环境如何改变肺部发育和宿主对甲型流感的反应
病毒感染后的生活我们的研究表明,年轻的成年(8周龄)小鼠暴露于100%的
出生后前4天的氧气简化了缺乏肺泡上皮II型(AECII)的肺泡,
先天免疫特权和肺泡干细胞。他们还表现出更大的炎症和纤维化肺
疾病时感染IAV(HKx 31,H3 N2)比感染同胞出生到室内空气。新生儿高氧
不损害病毒特异性抗体的产生、CD 8 +T细胞的细胞溶解功能或
有效清除病毒。相反,使用白喉A毒素(DTA)进行的基因耗竭研究支持以下观点:
AECII的氧依赖性损失负责增强远端肺泡细胞的原发性感染,
从而增加上皮损伤、炎症和纤维化肺病的严重性。鉴于AECIIs
保护肺部免受感染,随着肺部自然老化,它们的损失可能会导致肺部感染的增加。
在感染IAV的动物模型和老年人中观察到的呼吸道发病率。因此,本次修订
补充剂检验了老年小鼠AECII缺失将增强原发性感染的假设,
IAV类似于出生时暴露在高氧环境中的年轻成年小鼠。拟议的研究将
随着小鼠年龄的增长,绘制AECII的损失,并确定衰老如何增强远端肺泡的原发性感染,
细胞,从而导致更大的上皮损伤、炎症和纤维化肺病。了解如何
AECII的丧失影响小鼠中宿主-病原体相互作用是重要的,因为它可能导致新的
降低易感个体肺部疾病严重程度的疗法。
英文摘要
PROJECT SUMMARY (ABSTRACT)
Seasonal influenza A viruses (IAV) are responsible for considerable human morbidity and mortality
throughout the world. The risk for respiratory complications and hospitalization is highest among the elderly,
young children, and anyone with certain underlying or previous medical conditions, such as being born
preterm. Since preterm infants are often exposed to high oxygen, the parent grant uses mice to investigate
how an aberrant oxygen environment at birth alters lung development and the host response to influenza A
virus infection later in life. Our research has shown how young adult (8 week old) mice exposed to 100%
oxygen for the first 4 days of life have simplified alveoli that are deficient in alveolar epithelial type II (AECIIs),
an innate immune privileged and alveolar stem cell. They also exhibit greater inflammation and fibrotic lung
disease when infected with IAV (HKx31, H3N2) than infected siblings birthed into room air. Neonatal hyperoxia
does not impair production of virus specific antibodies, cytolytic functions of CD8+T cells, or the ability to
effectively clear virus. Instead, genetic depletion studies using diphtheria A toxin (DTA) support the idea that
the oxygen-dependent loss of AECIIs is responsible for enhancing primary infection of distal alveolar cells,
thereby increasing the severity of epithelial injury, inflammation, and fibrotic lung disease. Given that AECIIs
protect the lung against infection, their loss as the lung naturally ages could contribute to the heightened
respiratory morbidity seen in animal models and elderly humans infected with IAV. Hence, this Revision
Supplement tests the hypothesis that the loss of AECIIs in aged mice will enhance primary infection to
IAV similar to that of a young adult mouse exposed to high oxygen at birth. The proposed studies will
map the loss of AECIIs as mice age and determine how aging enhances primary infection of distal alveolar
cells, thereby resulting in greater epithelial injury, inflammation, and fibrotic lung disease. Understanding how
the loss of AECIIs influences host-pathogen interactions in mice is important because it could lead to new
therapies that reduce severity of lung diseases in susceptible individuals.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of early life hyperoxia on mesenchymal stem cell fate: their impact on age related disease
-
批准号:10312537
-
项目类别:
-
资助金额:$23.1万
-
财政年份:2021
-
负责人:Michael A O'Reilly
-
依托单位:
Role of early life hyperoxia on mesenchymal stem cell fate: their impact on age related disease
-
批准号:10475250
-
项目类别:
-
资助金额:$19.25万
-
财政年份:2021
-
负责人:Michael A O'Reilly
-
依托单位:
Effect of Neonatal Hyperoxia on Alveolar Development and Infection
-
批准号:9000732
-
项目类别:
-
资助金额:$38.38万
-
财政年份:2008
-
负责人:Michael A O'Reilly
-
依托单位:
Effect of Neonatal Hyperoxia on Alveolar Development and Infection
-
批准号:10001048
-
项目类别:
-
资助金额:$53.66万
-
财政年份:2008
-
负责人:Michael A O'Reilly
-
依托单位:
Effect of Neonatal Hyperoxia on Alveolar Development and Infection
-
批准号:9767838
-
项目类别:
-
资助金额:$53.66万
-
财政年份:2008
-
负责人:Michael A O'Reilly
-
依托单位:
Effect of Neonatal Hyperoxia on Alveolar Development and Infection
-
批准号:8630581
-
项目类别:
-
资助金额:$38.38万
-
财政年份:2008
-
负责人:Michael A O'Reilly
-
依托单位:
Effect of Neonatal Hyperoxia on Alveolar Development and Infection
-
批准号:7591323
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2008
-
负责人:Michael A O'Reilly
-
依托单位:
Effect of Neonatal Hyperoxia on Alveolar Development and Infection
-
批准号:10246362
-
项目类别:
-
资助金额:$53.66万
-
财政年份:2008
-
负责人:Michael A O'Reilly
-
依托单位:
Effect of Neonatal Hyperoxia on Alveolar Development and Infection
-
批准号:8197382
-
项目类别:
-
资助金额:$38.12万
-
财政年份:2008
-
负责人:Michael A O'Reilly
-
依托单位:
Effect of Neonatal Hyperoxia on Alveolar Development and Infection
-
批准号:7746428
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2008
-
负责人:Michael A O'Reilly
-
依托单位:
Effect of Neonatal Hyperoxia on Alveolar Development and Infection
-
批准号:7989991
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2008
-
负责人:Michael A O'Reilly
-
依托单位:
Core--Instrumentation Facility
-
批准号:6867266
-
项目类别:
-
资助金额:$17.65万
-
财政年份:2005
-
负责人:Michael A O'Reilly
-
依托单位:
DNA Repair and Replication in Oxidant Lung Injury
-
批准号:6924577
-
项目类别:
-
资助金额:$35.44万
-
财政年份:2002
-
负责人:Michael A O'Reilly
-
依托单位:
DNA Repair and Replication in Oxidant Lung Injury
-
批准号:6756459
-
项目类别:
-
资助金额:$35.44万
-
财政年份:2002
-
负责人:Michael A O'Reilly
-
依托单位:
Cell survival and death in oxidant lung injury
-
批准号:8661214
-
项目类别:
-
资助金额:$37.85万
-
财政年份:2002
-
负责人:Michael A O'Reilly
-
依托单位:
DNA Repair and Replication in Oxidant Lung Injury
-
批准号:6508966
-
项目类别:
-
资助金额:$35.44万
-
财政年份:2002
-
负责人:Michael A O'Reilly
-
依托单位:
Cell survival and death in oxidant lung injury
-
批准号:8279197
-
项目类别:
-
资助金额:$38.63万
-
财政年份:2002
-
负责人:Michael A O'Reilly
-
依托单位:
Cell Survival and Death in Oxidant Lung Injury
-
批准号:7266475
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2002
-
负责人:Michael A O'Reilly
-
依托单位:
DNA Repair and Replication in Oxidant Lung Injury
-
批准号:6629485
-
项目类别:
-
资助金额:$35.44万
-
财政年份:2002
-
负责人:Michael A O'Reilly
-
依托单位:
Cell Survival and Death in Oxidant Lung Injury
-
批准号:7388820
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2002
-
负责人:Michael A O'Reilly
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: